Searched for
ASTRAZENECA INVESTMENT
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- AstraZeneca to invest Rs 176 cr to expand GITC in ChennaiAstraZeneca is investing Rs 176 crore to expand its Global Innovation & Technology Centre in Chennai, marking its third investment in India...
- AstraZeneca expands Bengaluru global hub with Rs 166-cr investmentAstraZeneca is expanding its Bengaluru global hub with a Rs 166 crore investment, creating 400 jobs. This move will enhance R&D, global ser...
- AstraZeneca signs AI research deal with China's CSPC for chronic diseasesUnder Friday's agreement, the two companies will collaborate to discover and develop pre-clinical candidates, including a small molecule or...
- AstraZeneca to invest Rs 250 crore on expansion of its GCC in IndiaThe facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square fe...
- Mankind Pharma enters exclusive pact to distribute AstraZeneca's anti-asthma drug Symbicort in IndiaAstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca w...
- AstraZeneca to buy China's Gracell Bio for up to $1.2 billionThe cash deal, which adds several experimental therapies to AstraZeneca's portfolio, values Gracell at $2 per ordinary share, or $10 per AD...
- RDIF says early results of 'mix & match' of Sputnik Light, AstraZeneca jab found to be safeAstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.
- AstraZeneca sets up clinical data insights division in IndiaThe Bengaluru-based clinical data and insights (CDI) division is a critical advancement to support a growing global portfolio and build on ...
- AstraZeneca to test combining COVID-19 vaccine with Russian shotThe developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.
- AstraZeneca to invest $90 million in India over next 5 yearsThe announcement follows the signing of a bilateral innovation partnership for a sustainable future between Sweden and India.
- AstraZeneca inaugurates global technology centre in ChennaiThe company is also looking to develop additional technology centres with a second GTC planned for San Francisco in 2015.
- AstraZeneca planning to delist Indian subsidiary; likely to appoint Merrill Lynch as manager for delistingAstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...
- HCL Technologies replaces IBM as IT infra vendor of AstraZenecaHCL will deliver server virtualisation, storage and backup transformation and implementation of hybrid cloud for the AstraZeneca.
- AstraZeneca to axe 1,400 jobs in Europe, shuts three plantsAnglo-Swedish pharmaceuticals giant AstraZeneca said that it would slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Swe...
Load More
